Development and Assessment of Screening Nomogram for Biliary Atresia Based on Hepatobiliary Ultrasonographic Features
Open Access
- 17 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
Abstract
Objectives: Biliary atresia (BA) is a rare neonatal liver disease of which the early diagnosis remains a challenge for clinicians. Our center has established a nomogram diagnostic model based on clinical characteristics and liver function characteristics. We aim to develop and validate a nomogram that includes additional ultrasound and finds hepatobiliary abnormality with better BA early screening performance. Methods: In this single-center, retrospective cohort analysis, 1,001 neonatal obstructive jaundice (NOJ) patients between 2012 and 2015 were enrolled. Multivariable analysis was used to identify clinical characteristics, laboratory liver function characteristics, and ultrasonic features that may early screen BA. A nomogram was developed to predict the probability of BA using multiple logistic regression analysis. This nomogram was subsequently validated using another cohort of 501 NOJ patients between 2015 and 2017. Calibration curve analysis and decision curve analyses were performed to evaluate and interpret the nomogram's clinical benefits. Results: Gender, direct bilirubin (DB), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), fasting gallbladder visibility, fasting gallbladder filling, and common bile duct visibility were found to have profound statistical significance between the BA and non-BA groups (P < 0.05). The significant features were used to build the nomogram. The area under the receiver operating characteristic (ROC) curve (AUC) value of the novel nomogram (0.87) was superior to those of the former nomogram (0.83) and GGT alone (0.81) in the prediction of BA. The calibration curve revealed a close resemblance between the predicted and actual BA probabilities. Also, the net benefit from the decision curve analysis (DCA) of the nomogram (0.54) was superior to those of the former nomogram (0.49) and GGT alone (0.45) at 80% of threshold possibility. Conclusions: The nomogram has demonstrated better performance for BA screening by including additional information of the US finding, holding a promising future as a non-invasive method for BA patients.Funding Information
- Key Disciplines Construction Project of Shanghai Municipal (2017ZZ02022)
- National Natural Science Foundation of China (81770519, 81771633, 81873545, 81974059)
- Natural Science Foundation of Shanghai (14411969800, 16411952200, 18411969100, 19ZR1406600)
This publication has 29 references indexed in Scilit:
- Ultrasound for the Diagnosis of Biliary Atresia: A Meta-AnalysisAmerican Journal of Roentgenology, 2016
- Ultrasound Scanning in Infants with Biliary Atresia: The Different Implications of Biliary Tract Features and Liver EchostructureUltraschall in der Medizin - European Journal of Ultrasound, 2013
- Efficacy of US-guided Percutaneous Cholecystocholangiography for the Early Exclusion and Type Determination of Biliary AtresiaRadiology, 2011
- Biliary atresiaThe Lancet, 2009
- Biliary atresia: making the diagnosis by the gallbladder ghost triadPediatric Radiology, 2003
- Evaluation of the Triangular Cord Sign in the Diagnosis of Biliary AtresiaPEDIATRICS, 2001
- Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresiaJournal of Pediatric Surgery, 2001
- Biliary Atresia in Neonates and Infants: Triangular Area of High Signal Intensity in the Porta Hepatis at T2-weighted MR Cholangiography with US and Histopathologic CorrelationRadiology, 2000
- The frequency and outcome of biliary atresia in the UK and IrelandThe Lancet, 2000